The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 18, 2017

Filed:

Jan. 08, 2009
Applicants:

Dov Tamarkin, Maccabim, IL;

Doron Friedman, Karmei Yosef, IL;

Meir Eini, Ness Ziona, IL;

Alex Besonov, Rehovot, IL;

Inventors:

Dov Tamarkin, Maccabim, IL;

Doron Friedman, Karmei Yosef, IL;

Meir Eini, Ness Ziona, IL;

Alex Besonov, Rehovot, IL;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/04 (2006.01); A61K 8/96 (2006.01); A61K 47/14 (2017.01); A61K 47/06 (2006.01); A61K 47/10 (2017.01); A61K 9/00 (2006.01); A61K 35/04 (2006.01); A61K 9/12 (2006.01); A61K 8/37 (2006.01); A61K 8/31 (2006.01); A61Q 19/00 (2006.01); A61Q 19/02 (2006.01); A61Q 19/08 (2006.01); A01N 25/16 (2006.01);
U.S. Cl.
CPC ...
A61K 8/046 (2013.01); A61K 8/31 (2013.01); A61K 8/37 (2013.01); A61K 8/375 (2013.01); A61K 8/965 (2013.01); A61K 9/0014 (2013.01); A61K 9/122 (2013.01); A61K 35/04 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/14 (2013.01); A61Q 19/00 (2013.01); A01N 25/16 (2013.01); A61Q 19/02 (2013.01); A61Q 19/08 (2013.01);
Abstract

The present invention relates to a foamable vehicle or cosmetic or pharmaceutical composition, comprising: (1) an organic carrier, at a concentration of 10% to 70% by weight, wherein said organic carrier concurrently comprises: (i) at least one hydrophobic organic carrier, and (ii) at least one polar solvent; (2) at least one surface-active agent; (3) water; and (4) at least one liquefied or compressed gas propellant at a concentration of 3% to 25% by weight of the total composition. The present invention further provides a method of treating, alleviating or preventing a disorder of mammalian subject, comprising administering the above-mentioned compositions to an afflicted target site.


Find Patent Forward Citations

Loading…